Literature DB >> 19238864

Plasma matrix metalloproteinase levels do not predict tissue levels in abdominal aortic aneurysms suitable for elective repair.

W Richard W Wilson1, Edward C Choke, Joseph Dawson, Ian M Loftus, Matthew M Thompson.   

Abstract

The role of matrix metalloproteinases (MMPs) in abdominal aortic aneurysm (AAA) pathogenesis is well described. However, a clear role for the MMPs in disease prediction has not been established. The aim of this study was to determine if circulating levels of MMPs correlated with AAA diameter and with MMP concentrations within the aneurysm wall. Preoperative plasma samples and intraoperative infrarenal AAA sac biopsies were taken in a standard fashion from 31 patients undergoing elective repair.The concentrations of MMP-1, MMP-2, MMP-3, MMP-9, tissue inhibitor of matrix metalloproteinase (TIMP)-1, and TIMP-2 were quantified in plasma and aneurysm wall homogenates using enzyme-linked immunosorbent assay. Comparison used the Spearman correlation. There were no correlations between the paired plasma and aneurysm wall concentrations for any MMP or TIMP. Correlation between MMP-9 levels in the aneurysm wall and aneurysm diameter was negative (r = -.42, p = .019). Other correlations between plasma and tissue levels with aneurysm diameter were nonsignificant.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19238864     DOI: 10.2310/6670.2008.00043

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  8 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 2.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

Review 3.  Preventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicine.

Authors:  Alain Li-Wan-Po; Bart Loeys; Peter Farndon; David Latham; Caroline Bradley
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

Review 4.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

Authors:  Jie Liu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-10       Impact factor: 3.622

Review 5.  Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects.

Authors:  Joseph V Moxon; Adam Parr; Theophilus I Emeto; Philip Walker; Paul E Norman; Jonathan Golledge
Journal:  Curr Probl Cardiol       Date:  2010-10       Impact factor: 5.200

6.  Association of statin prescription with small abdominal aortic aneurysm progression.

Authors:  Craig D Ferguson; Paula Clancy; Bernard Bourke; Philip J Walker; Anthony Dear; Tim Buckenham; Paul Norman; Jonathan Golledge
Journal:  Am Heart J       Date:  2010-02       Impact factor: 4.749

7.  Matrix metalloproteinase levels in chronic thoracic aortic dissection.

Authors:  Xiaoming Zhang; Darrell Wu; Justin C Choi; Charles G Minard; Xinguo Hou; Joseph S Coselli; Ying H Shen; Scott A LeMaire
Journal:  J Surg Res       Date:  2014-03-19       Impact factor: 2.192

8.  Preservation of Smooth Muscle Cell Integrity and Function: A Target for Limiting Abdominal Aortic Aneurysm Expansion?

Authors:  Emily R Clark; Rebecca J Helliwell; Marc A Bailey; Karen E Hemmings; Katherine I Bridge; Kathryn J Griffin; D Julian A Scott; Louise M Jennings; Kirsten Riches-Suman; Karen E Porter
Journal:  Cells       Date:  2022-03-19       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.